Real-time enrollment status for this recurrent glioblastoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 2:54 PM UTC
| NCT Number | NCT06910306 |
| Recruiting Status | Recruiting |
| Condition | Recurrent Glioblastoma |
| Phase | Clinical Trial |
| Target Enrollment | 10 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Alpha Tau Medical LTD. |
| Last Updated on CT.gov | June 16, 2026 (3 weeks ago) |
As of July 13, 2026: Clinical trial NCT06910306 is currently recruiting participants. This clinical trial study for recurrent glioblastoma is actively seeking new participants at 3 locations across the United States. The study is sponsored by Alpha Tau Medical LTD.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06910306 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06910306 was last updated 3 weeks ago (June 16, 2026). HelloStudys verifies this status automatically.